David Brodner, MD
Otolaryngology · Boynton Beach, FLNPI 1144284902
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $181,067 of the $209,170 with a category attached, or 86.6%. Stryker accounts for 92.3% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $94,523 and has fallen 97.9% since, to $1,974 in 2025. Among otolaryngology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 362 payments — averaging $577.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$193K
- Nestle Healthcare Nutrition Inc.$9K
- Aerin Medical Inc.$3K
- Optinose US, Inc.$903
- Medical Device Business Services, Inc.$781
- Acclarent, Inc$608
- plus $2K from 15 others
Across 1 payment — averaging $1250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aerin Medical Inc.$1K
What the payments were for
- Consulting fees$181,06787%
- Travel & lodging$18,5339%
- Food & beverage$9,4715%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 229 | $193,122 |
| Nestle Healthcare Nutrition Inc. | 3 | $9,250 |
| Aerin Medical Inc. | 41 | $2,606 |
| Optinose US, Inc. | 28 | $903 |
| Medical Device Business Services, Inc. | 1 | $781 |
| Acclarent, Inc | 14 | $608 |
| Gyrus ACMI, Inc. | 1 | $525 |
| Jazz Pharmaceuticals Inc. | 14 | $386 |
| Medtronic(2 entities) | 4 | $374 |
| GSK | 5 | $116 |
| Lilly USA, LLC | 5 | $106 |
| Idorsia Pharmaceuticals US Inc | 5 | $78 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $54 |
| Fisher & Paykel Healthcare Inc | 1 | $54 |
| Neurent Medical Limited | 2 | $50 |
| Resmed Corp | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Merck | 1 | $19 |
| Smith+Nephew | 1 | $18 |
| Shire North American Group Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENTELLUS - XPRESS ENT DILATION SYSTEM$110,731
- XPRESS ENT DILATION SYSTEM$55,007
- CLARIFIX CRYOTHERAPY DEVICE$51,929
- LATERA$50,817
- SCOPIS ENT$31,531
- TGS GUIDEWIRE$18,616
- ENTELLUS MEDICAL REINFORCED ANESTHESIA NEEDLE$12,000
- ORTHOMAP$10,800
- SHAVER SYSTEM$7,617
- 1688$6,617
- CYCLONE SINONASAL SUCTION/IRRIGATION SYSTEM$6,514
- XEROGEL NASAL/EPISTAXIS 2 PACK$6,514
- VIVAER STYLUS$1,207
- VivAer$529
- RhinAer$529
- ENT - High Speed Drill Capital$525
- ENT - High Speed Drill Disposabl$525
- ENT Other Capital$525
- ENT Other Disposables$525
- Xhance$521
How this compares
$209,170 in reported general payments places this provider in the 95th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 491 | $13,459 |
| QuviviqDaridorexant Hcl | 12 | $5,658 |
| Epinephrine | 18 | $2,953 |
| Fluocinolone Acetonide Oil | 29 | $960 |
| Prednisone | 97 | $439 |
| Azithromycin | 79 | $326 |
| Zolpidem Tartrate ErZolpidem Tartrate | 11 | $225 |
| Eszopiclone | 14 | $95 |
| Zolpidem Tartrate | 22 | $90 |
| Triazolam | 21 | $67 |
| Tramadol Hcl | 45 | $56 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $48 |
| Montelukast Sodium | 17 | $45 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Idorsia Pharmaceuticals US IncQuviviq | $78 | $5,65812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 586 otolaryngology providers in Florida.
Other otolaryngology in Boynton Beach
- Alfredo ArchillaBoynton Beach$22K
- Cecelia DamaskOrlando$707K
- Ralph TufanoSarasota$469K
- Franklin RimellFort Myers$314K
- Maria SuurnaMiami$189K
- Jane DillonOrmond Beach$180K
- Jeb JusticeGainesville$142K
- Indranil DebnathWinter Park$109K
- Agustin ArrietaMiami$95K
- John WestineGainesville$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.